Cancer Clinical Trial - Novita NP-G2-044-P1-01

Cancer

Status:

Open (Study open and enrolling)

ClinicalTrials.gov:

NCT03199586

CONDITIONS(S): Advanced Solid Tumors - TRIAL: Novita NP-G2-044-P1-01 - Phase 1 Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Solid Tumors (Including Lymphoma)

First-in-human phase 1 study to determine safety of NP-G2-044 when given orally on a daily X 28 days followed by a 14 day rest period.

Drug

NP-G2-044

Trial Type

Interventional

Age Range

18 years or older

Phase

Phase 1

Condition

Advanced solid tumors

Keywords

Novita | Metastasis Inhibitor NP-G2-044 | NP-G2-044